Shakira Concertgoers Warned of Possible Measles Exposure
On Tuesday, the New Jersey Department of Health issued a statement warning anyone who was at the stadium between 7:30 p.m. on May 15 and 1:00 a.m. on May 16 may have been exposed to measles.
"The New Jersey Department of Health (NJDOH) is alerting residents about potential exposures associated with a newly identified case of measles in a non-NJ resident who attended a concert in NJ while infectious. Individuals – especially parents, guardians, health care providers, and caregivers – are urged to be aware of the symptoms of this highly contagious virus and to ensure they are up to date with the measles, mumps, and rubella (MMR) shots," the New Jersey Department of Health said in a statement.
"Measles symptoms include a high fever, cough, runny nose, watery red eyes, and a rash that usually appears between three and five days after symptoms begin. The rash usually begins as flat red spots that appear on the face at the hairline and spread downward to the neck, torso, arms, legs, and feet. Measles can also cause serious complications, such as pneumonia and encephalitis (swelling of the brain), and can lead to miscarriage in pregnant people, premature birth, or a low-birth-weight baby."
The NJDOH warns that the highly contagious virus spreads easily through the air when someone coughs or sneezes, adding that it can remain in the air for up to two hours after an infected person leaves the area.
Those who have not been fully vaccinated or have not had measles in the past are at most risk, the NJDOH warns, adding that the best way to protect yourself from measles, mumps, and rubella is by taking the MMR vaccine.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
8 hours ago
- Business Wire
Performant Healthcare, Inc. Announces Preliminary Financial Results for Second Quarter 2025
PLANTATION, Fla.--(BUSINESS WIRE)--Performant Healthcare, Inc. (Nasdaq: PHLT) (the 'Company' or 'Performant'), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, today announced preliminary financial results for the second quarter of 2025. Performant will no longer hold its second quarter results conference call originally scheduled for Tuesday, August 5, 2025 Share Second Quarter 2025 Results The Company currently expects to file its Form 10-Q for the quarter ended June 30, 2025 on August 7, 2025 and anticipates reporting second quarter revenues of approximately $37.8 million, net income of approximately $2.1 million, and adjusted EBITDA of approximately $6.2 million. Transaction with Machinify In a separate press release issued today, Performant announced its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio company of New Mountain Capital. As a result, Performant will no longer hold its second quarter results conference call originally scheduled for Tuesday, August 5, 2025. Performant is also withdrawing its previously issued full-year 2025 guidance. Note Regarding Use of Non-GAAP Financial Measures In this press release, the Company presents adjusted EBITDA. This measure is not in accordance with accounting principles generally accepted in the United States of America ('US GAAP') and accordingly reconciliation of adjusted EBITDA determined in accordance with US GAAP is included in the 'Reconciliation of Non-GAAP Results' table at the end of this press release. We have included adjusted EBITDA in this press release because it is a key measure used by our management and board of directors to understand and evaluate our core operating performance and trends and to prepare and approve our annual budget. Accordingly, we believe that adjusted EBITDA provides useful information to investors and analysts in understanding and evaluating our operating results in the same manner as our management and board of directors. Our use of adjusted EBITDA has limitations as an analytical tool and should not be considered in isolation or as a substitute for analysis of our results as reported under US GAAP. In particular, many of the adjustments to our US GAAP financial measures reflect the exclusion of items, specifically interest, tax, and depreciation and amortization expenses, equity-based compensation expense and certain other non-operating expenses that are recurring and will be reflected in our financial results for the foreseeable future. In addition, these measures may be calculated differently from similarly titled non-GAAP financial measures used by other companies, limiting their usefulness for comparison purposes. ABOUT PERFORMANT Performant supports healthcare payers in identifying, preventing, and recovering waste and improper payments by leveraging advanced technology, analytics and proprietary data assets. Performant works with leading national and regional healthcare payers to provide eligibility-based, also known as coordination-of-benefits (COB) services, as well as claims-based services, which includes the audit and identification of improperly paid claims. Performant is a leading provider of these services in both government and commercial healthcare markets. Performant also provides advanced reporting capabilities, support services, customer care, and stakeholder training programs designed to mitigate future instances of improper payments. To learn more about Performant, please visit Forward Looking Statements This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company's outlook for revenues, net income (loss), and adjusted EBITDA in 2025 and beyond. These forward-looking statements are based on current expectations, estimates, assumptions, and projections that are subject to change and actual results may differ materially from the forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to: the Company's ability to generate revenue following long implementation periods associated with new customer contracts; client relationships and the Company's ability to maintain such client relationships; our commercial client growth strategy; many of the Company's customer contracts being subject to periodic renewal, not being exclusive, and not providing for committed business volumes; anticipated trends and challenges in the Company's business and competition in the markets in which it operates; the Company's indebtedness and compliance, or failure to comply, with restrictive covenants in the Company's credit agreement; opportunities and expectations for growth in the various markets in which the Company operates; the Company's ability to hire and retain employees with specialized skills that are required for its healthcare business; downturns in domestic or global economic conditions and other macroeconomic factors; the Company's ability to generate sufficient cash flows to fund our ongoing operations and other liquidity needs; the impact of public health emergencies, such as the COVID-19 pandemic, on the Company's business and operations, opportunities and expectations for the markets in which the Company operates; the impacts of a failure of the Company's operating systems or technology infrastructure or those of third-party vendors and subcontractors; the impacts of a cybersecurity breach or related incident to the Company or any of the Company's third-party vendors and subcontractors; the adaptability of the Company's technology platform to new markets and processes; the Company's ability to invest in and utilize data and analytics capabilities to expand our capabilities; the Company's growth strategy of expanding in existing markets and considering strategic alliances or acquisitions; the Company's ability to maintain, protect and enhance its intellectual property; expectations regarding future expenses; expected future financial performance; and the Company's ability to comply with and adapt to industry regulations and compliance demands. More information on potential factors that could affect the Company's financial condition and operating results is included from time to time in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's annual report on Form 10-K for the year ended December 31, 2024 and subsequently filed reports on Forms 10-Q and 8-K. The forward-looking statements are made as of the date of this press release and the Company does not undertake to update any forward-looking statements to conform these statements to actual results or revised expectations.
CNN
9 hours ago
- CNN
Record share of US kindergartners missed required vaccinations last year, ahead of surge in measles cases
A record share of US kindergartners had an exemption for a required vaccination last school year, and coverage for all reported vaccines – including the measles vaccine – was lower than the year before, according to new data published Thursday by the US Centers for Disease Control and Prevention. About 3.6% of incoming kindergartners in the 2024-25 school year had an exemption for a required vaccine, leaving about 138,000 new schoolchildren without full coverage for at least one state-mandated vaccine, the new data shows. Exemptions jumped more than a full percentage point over the past four years, the CDC data shows, and the vast majority – all but 0.2% – were for non-medical reasons. About 286,000 kindergartners had not completed the measles-mumps-rubella (MMR) vaccination series in the 2024-25 school year, as cases climbed this year to the highest they've been since the disease was declared eliminated in the US a quarter-century ago. MMR coverage dropped to 92.5%, marking the fifth year in a row that coverage has been below the federal target of 95%, according to the CDC data. The vast majority of this year's measles cases have been in unvaccinated children. 'Vaccination remains the most effective way to protect children from serious diseases like measles and whooping cough, which can lead to hospitalization and long-term health complications,' the CDC said in a statement. 'CDC is committed to working closely with state and local partners by providing tools, resources, and data that help communities promote vaccine access and awareness.' But the statement also echoed language that is often used by US Department of Health and Human Services Secretary Robert F. Kennedy Jr., saying that 'the decision to vaccinate is a personal one. Parents should consult their healthcare providers on options for their families.' Forty-five states allow religious beliefs to be used as a basis for a vaccine exemption for children beginning school, and 15 states allow exemptions for other personal or philosophical reasons, according to the American Academy of Pediatrics. 'As pediatricians, we know that immunizing children helps them stay healthy, and when everyone can be immunized, it's harder for diseases to spread in our communities,' Dr. Susan Kressly, president of the AAP, said in a statement. 'At this moment when preventable diseases are on the rise, we need clear, effective communication from government leaders recommending immunizations as the best way to ensure children's immune systems are prepared to fight dangerous diseases.' This week, the organization reaffirmed its longstanding position that non-medical exemptions to school immunization requirements should be eliminated. 'The science behind vaccines demonstrates that the benefits greatly outweigh any potential risks,' said Dr. Sean O'Leary, a pediatric infectious disease specialist and chair of the AAP Committee on Infectious Diseases. 'There really aren't good reasons to opt out.' However, in the 2024-25 school year, vaccine exemptions increased in 36 states, according to the new CDC data. In 17 states, more than 5% of kindergartners had exemptions – meaning reminders from administrators to complete paperwork or doctor's visits won't be enough to raise coverage to the 95% goal for two doses of MMR vaccine set by HHS, a threshold necessary to help prevent outbreaks of the highly contagious disease. 'There are more and more states where even the potentially achievable coverage that we can get by catching everyone up who's overdue is getting lower and lower,' said Dr. Josh Williams, a pediatrician with Denver Health and associate professor at the University of Colorado Anschutz Medical Campus. 'So we are now in a situation where in many states, and certainly in many communities within certain states, there's simply not enough herd immunity to protect against outbreaks of these vaccine-preventable diseases, especially measles.' In a study from 2019, Williams and fellow researchers found interesting patterns in vaccine exemptions: When both religious and personal belief exemptions are available in a state, religious exemptions tend to be low, but rates of religious exemptions increase significantly when the personal belief exemption goes away. 'That leads to the kinds of recommendations that you see from organizations like the AAP, basically saying it appears that these exemption policies are not really doing what they were intended to do, that people are kind of using these perhaps in the ways that they were not intended,' he said. Only five states limit vaccine exemptions to medical reasons, according to the AAP: California, Connecticut, Maine, New York and West Virginia. Numbers on MMR coverage in West Virginia were not available in the latest data from the CDC, but the four other states are among the small group of 10 states that reached the federal goal of 95% coverage among kindergartners. In 2023, a federal court paved the way for religious exemptions to be added to Mississippi school vaccination policy. Exemption rates immediately jumped in the state, and MMR coverage has dropped about 1 percentage point, CDC data shows. Overall, nationwide MMR coverage among kindergartners dropped from 92.7% in the 2023-24 school year to 92.5% in the 2024-25 school year, according to the CDC. Experts say that a change like this may seem small but can significantly raise risks. 'It's a small percentage point change that adds up if it happens year over year, and that is what we've been seeing,' Williams said, and the change isn't distributed evenly. 'Individuals who tend to refuse vaccines tend to cluster together. … It's probably that the areas where there have been low uptake now have even worse uptake, and the areas where there have been more reasonable uptake continue to stay reasonable.' The vast majority of measles cases reported in this record-breaking year have been concentrated in Texas. MMR coverage in the state has been trending down for at least the past decade, CDC data shows, with just 93.2% coverage among kindergartners. Exemptions have surged past 4% – well above the national rate – and a law passed by the state legislature this year would make it even easier to get an exemption. Starting in September, the affidavit form to file for an exemption will be available to print from the state health department's website, without the need to file a written request. There was a lot of testimony opposing this change, said Dr. Philip Huang, director of the Dallas County health department. 'We were making the point during the whole thing that there needs to be a consistent message of unequivocal support for vaccinations from the top,' he said. 'We're very concerned about what's happening with HHS and the messaging sort of undermining that.' Experts say that vaccines can sometimes be 'victims of their own success,' with people not realizing how much protection they offer until they see the suffering that can happen when they're not utilized. This year's measles outbreak – which has led to three deaths and dozens of hospitalizations, mostly among children – may raise the urgency around the need to vaccinate and help to start to turn the trend around, experts say. 'The declines that we're seeing for measles and for other vaccines are always concerning, but perhaps in the context of one of our larger measles outbreaks in recent memory, I think a lot of people have it in mind with returning to school this fall,' Williams said. 'In my clinical practice here in Denver, we are getting requests from families who are worried about measles transmission in school and in day care. We've had some families coming in who want to get that protection on board prior to the school year beginning to make sure that their child is going to be as protected as possible prior to going back to school this fall.' Williams says he likes to remind parents that most people support vaccination and that he works hard to gain the trust of parents who are hesitant. 'It's always good to remember that the vast majority of parents vaccinate their kids on time and according to the recommended schedule,' he said. 'When that's not true in a school or in a community, I think that's an opportunity for advocates to speak up and talk to other parents and be partners in the process of improving vaccine confidence.'
UPI
16 hours ago
- UPI
Vaccination rates of U.S. kindergartners down, measles cases up
A MMR vaccine information packet is seen at City of Lubbock Health Department in Lubbock, Texas, in March. According to an update from the Texas Department of State Health Services on Friday, there was was an outbreak of measles in the South Plains region of Texas where 146 cases were identified as of late January. New CDC data shows that vaccination rates are down in the United States. Photo by Annie Rice/EPA-EFE July 31 (UPI) -- Vaccination rates among U.S. kindergarten students decreased during the 2024-2025 school year, according to data released Thursday by the U.S. Centers for Disease Control and Prevention and the District of Columbia. Rates ranged from 92.1% for diphtheria, tetanus and pertussis to 92.5% for measles, mumps and rubella. Vaccination rates for polio and varicella dropped in more than half of the states compared to a year prior, the data show. "The number of kindergarteners attending school without documentation of completing the MMR vaccine series was about 286,000 during the 2024-2025 school year," the report said. Overall, the number of kindergartners exempt from one or more vaccines during the 2024-2025 school year reached nearly 138,000, the data showed. The drop in vaccination rates comes amid an uptick in the number of measles cases in the United States. There have been 29 reported outbreaks in 2025, compared with 16 in 2024. Of 1,156 cases reported so far this year, 87% of them have been confirmed, compared to 198 of 285 confirmed cases, or 69%, in 2024.
